O Trademark

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in identifying genetic markers for inherited diseases, genetic predispositions, and drug responses and for disease detection, namely, COVID-19, total cholesterol, HDL, LDL, total triglycerides, HbA1C, ALT, AST, and blood pressure

Providing health screening tests in the fields of infectious diseases, cardiovascular diseases, metabolic diseases, respiratory diseases, neurological diseases, renal diseases, cancer, genetic disorders, behavioral and mental health, and cancer risk assessments; medical information services, namely, reporting of authorized clinical testing results; DNA analysis and screening for diagnostic purposes and for the purpose of providing medical information; providing a website featuring medically relevant information regarding genetics and infectious diseases for educational purposes; providing health and wellness information and public health information in connection with infectious disease and genetics; genomics consulting services, namely, genetic counseling; consulting services in the fields of diagnostic medical testing

Genomic testing for scientific research purposes; providing online databases containing scientific and genomic information in the nature of results of sequencing genes of interest in the human genome; SaaS services, namely, software enabling individuals to view results of laboratory tests and informational reports; analysis of genetic information for scientific research purposes and for the purpose of providing individuals with scientific information about genetics; providing an online open database featuring scientific information about human genetics to enable researchers to understand human genetic information; SaaS services featuring software for performing health assessments and health screening tests; SaaS services featuring software for storing, tracking, managing, analyzing, reporting, and aggregating health screening results and public and personal health data; SaaS services featuring software for reviewing and accessing genetic sequencing information and for reviewing and accessing genetic sequencing analysis, and annotated results of health data and health screening results for purposes of enabling health initiatives and public health reporting; SaaS services featuring software for population data analysis, namely, software for use in testing for and vaccinating against communicable diseases, compliance, and demographics analysis